Enviomycin
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IM |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H43N13O10 |
Molar mass | 685.700 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]
References
- ^ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
- ^ Selvakumar N, Kumar V, Acharyulu GS, Rehman F, Paramasivan CN, Prabhakar R (May 1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian Journal of Medical Research. 95: 101–4. PMID 1506058.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Drugboxes which contain changes to verified fields
- Polypeptide antibiotics
- All stub articles
- Antiinfective agent stubs